# Drug Development

AlphaProteo is the first AI system launched by DeepMind designed to create novel, high-affinity protein complexes as building blocks for biological and health research. This technology has the potential to accelerate our understanding of biological processes and support drug discovery and biosensor development. AlphaProteo can generate new protein complexes for a variety of target proteins, including VEGF-A, which is associated with cancer and diabetes complications. It outperforms existing methods in terms of experimental success rates and binding affinity, significantly reducing the time needed for preliminary experiments involving protein complexes.

JADBio is a no-code machine learning platform that accelerates the drug discovery process through automated biomarker discovery and interpretation. It can handle multi-omics data, including genomics, transcriptomics, and metabolomics, providing researchers with rapid and efficient data analysis and insights. JADBio's strength lies in its user-friendly interface and automation capabilities, significantly reducing the time and cost of drug development. Pricing information is available on the official website.

Lavo Life Sciences is an early-stage startup accelerating drug development through the creation of software tools. Our AI-powered chemical simulation speeds up and provides more cost-effective and reliable drug property prediction compared to existing solutions. Our software simulates the behavior of drugs at the atomic level, helping pharmaceutical companies bring treatments to patients faster. Accelerate your drug discovery process with our technology.